Placental effects and transfer of sildenafil in healthy and preeclamptic conditionsResearch in context
Background: The phosphodiesterase-5 inhibitor (PDE5) sildenafil has emerged as a promising treatment for preeclampsia (PE). However, a sildenafil trial was recently halted due to lack of effect and increased neonatal morbidity. Methods: Ex vivo dual-sided perfusion of an isolated cotyledon and wire-...
Main Authors: | Emilie Hitzerd, Michelle Broekhuizen, Katrina M. Mirabito Colafella, Marija Glisic, René de Vries, Birgit C.P. Koch, Michiel A. de Raaf, Daphne Merkus, Sam Schoenmakers, Irwin K.M. Reiss, A.H. Jan Danser, Sinno H.P. Simons |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-07-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396419303822 |
Similar Items
-
Differences in Placental Imprinted Gene Expression across Preeclamptic and Non-Preeclamptic Pregnancies
by: Maya A. Deyssenroth, et al.
Published: (2020-09-01) -
Larger First-Trimester Placental Volumetric Parameters Are Associated With Lower Pressure and More Flow-Mediated Vasodilation of the Fetoplacental Vasculature After Delivery
by: Emilie Hitzerd, et al.
Published: (2020-01-01) -
Comparing Serum and 24-hour Urine Calcium between Preeclamptic and Non-preeclamptic Patients
by: N Shahbazian, et al.
Published: (2014-02-01) -
Immunohistochemical Analysis of Placental Microvessel Density and Spiral Artery Doppler Results in Preeclamptic Pregnancies
by: Bahar Ergen, et al.
Published: (2018-07-01) -
Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia.
by: Alessandro Rolfo, et al.
Published: (2013-01-01)